Comité del programa
-
Asami Ezaki, PhD Division Director, PR Section, Office of Planning and Operations
Pharmaceuticals and Medeical Devices Agency (PMDA), Japan -
Yasuhiro Honsho Associate Director, Safety & Risk Management Department
Daiichi Sankyo, Japan -
Yuji Ito Prescribing Information Group, RA Functions Dept., Regulatory Affairs Japan
Novartis Pharma K.K., Japan -
Kana Maruyama Manager, Regulatory Labeling, Regulatory Affairs
Viatris Pharmaceuticals Japan GK, Japan -
Ken Nakajima, RPh Quality Assurance Division Safety Management Department
Otsuka Pharmaceutical Factory, Inc, Japan -
Yuji Ohne Senior Director of Regulatory Compliance
Aurion Biotech Japan, Japan -
Keinosuke Okazaki Pharmacovigilance, Safety-1
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Mikiko Shitara
Gene And Serve , Japan -
Rie Matsui, RPh Senior Director, Regional Labeling Head for APAC
Pfizer R&D Japan G.K., Japan -
Akiyoshi Uchiyama President
Artage Inc., Japan
¿Tiene una cuenta?